US 8,247,370 B2Granted

Conjoint therapy for treating fibrotic diseases

AssigneePromedior, Inc.

InventorTimothy J. Pelura

Life of this patent

Estimating the term…

Abstract

The present invention relates to improved methods of treating fibrotic or fibroproliferative disorders. Conjoint therapies are provided comprising the combination of one or more fibrocyte suppressors and one or more profibrotic factor antagonists or anti-fibrotic agents.

Claims4

Dependent claims

A method of treating fibrosis, the method comprising administering to a patient in need thereof a combination of a Serum Amyloid P (SAP) protein and enalapril.

Dependencies are inferred from the claim text.

Facts

Application: 12/448,035Filed 4 Dec 2007 · us provisional application
Priority: 4 Dec 2006
Published: US 2010/0111898 A16 May 2010
Granted: 21 Aug 2012
Term ends: Not estimatedThe source records don’t support an estimate.

Classification47 codes

A61K 38/217
Interferons [IFN]: iFN-gamma
A61K 38/1716
From mammals: amyloid plaque core protein
A61K 38/208
Interleukins [IL]: il-12
A61K 38/39
From animals; from humans: connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]

Family

Application60/872,730Us provisional application · filed 4 Dec 2006
US 2010/0111898 A1Pre-grant publication · published 6 May 2010
US 8,247,370 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results